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Melioidosis is often considered an exotic and uncommon disease in most parts of the world. However it
is an endemic disease in Southeast Asia and Northern Australia with an expanding distribution.
Melioidosis can involve almost any organ and can deteriorate rapidly. In this report, we describe a rapidly
fatal case of a mycotic aneurysm associated with melioidosis despite aggressive antibiotic therapy. The
morbidity and mortality of this uncommon complication remains high despite prompt diagnosis and
treatment. Especially when treating persistent/recurrent melioidosis, the physician's caution to the
development of mycotic aneurysms is imperative so that early treatment and surgical intervention may
be considered.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Melioidosis is a granulomatous infectious disease caused by the
aerobic Gram-negative bacillus Burkholderia pseudomallei usually
found in contaminatedwater and soil. It is considered a rare disease
in most parts of the world but is endemic in Southeast Asia and
Northern Australia. It often presents as community-acquired
pneumonia and sepsis, but can involve almost any part of the
body. In this case report, we illustrate a rare but fatal complication
of this increasingly reported and important disease.Case report
An 82 year old man presented with fever and cough for a few
days. Hewas an ex-smoker and ex-social drinker, and had history of
myocardial infarction treated by coronary angioplasty with stenting
4 years ago. The patient was a retired water pipe worker with good
functional status. There was no history of diabetes, renal or lung
disease.
Upon admission, chest x-ray (CXR) showed right lower zone
consolidation and blood/urine biochemistry revealed hypona-
tremia consistent with syndrome of inappropriate antidiuretic
hormone secretion (SIADH). Complete blood count (CBC) wasnit, Grantham Hospital, 125
852 25182111.
Ltd. This is an open access article uunremarkable but inﬂammatory markers (erythrocyte sedimenta-
tion rate [ESR], C-reactive protein [CRP]) were elevated. The case
was treated as community-acquired pneumonia and hewas started
on empirical intravenous amoxillcin þ clavulanate and azi-
thromycin. He improved with treatment but blood culture yielded
B. pseudomallei (sensitive to ceftazidime). Computed tomography
(CT) scan showed bilateral lower and right middle lobe consolida-
tion; the abdomen and pelvis were unremarkable and there was no
evidence of other organ involvement. He was treated with a three
week course of intravenous ceftazidime and then switched to an
eradication phase of oral amoxillinþ clavulante and doxycycline for
three more months. There was complete resolution of symptoms
and serial CXRs were clear. Repeat blood culture showed clearance
of B. pseudomallei. Reassessment CT performed in August 2014
showed largely resolved consolidative changes. The patient
completed the course of oral antibiotics in September 2014. He
remained well and there was no signiﬁcant travel or contact
history.
However he experienced fever and cough again three weeks
after cessation of antibiotic therapy. CXR on presentation showed
no new abnormalities, but blood tests again conﬁrmed SIADH with
raised inﬂammatory markers and B. pseudomallei septicaemia
(sensitive to ceftazidime). He was restarted on ceftazidime but his
symptoms and fever persisted. Ceftazidime was switched to mer-
openam but still without signs of clinical improvement. Serial
blood cultures showed persistent B. pseudomallei septicaemia
without change in antibiotic susceptibility. Whole body positron
emission tomographyeCT (PET-CT) was performed, which revealednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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perior mediastinum associated elevated ﬂuorodeoxyglucose (FDG)
uptake, consistent with mycotic aneurysm of the aortic arch/left
subclavian artery; and patchy FDG uptakes are noted within the
vertebral bodies of the cervical and thoracic spine, suggestive of
possible bone involvement (Fig. 1). Echocardiogram showed a
structurally normal heart and no vegetations were seen. The
dihydrorhodamine reduction (DHR) test revealed a low oxidative
burst response.
In view of possible intravascular/bone involvement, the mer-
openam dose was escalated and doxycycline was added but still
without clinical improvement. The patient was assessed by our
cardiothoracic and vascular teams, but was deemed not suitable for
surgery. Doxycycline was replaced by intravenous minocycline, and
moxiﬂoxacin was also added. However blood cultures were
persistently positive for B. pseudomallei and the patient continued a
downhill course. Serial CXR and CT (Fig. 2) showed rapid interval
enlargement of aortic arch aneurysm. Despite continued antibiotic
and supportive treatment, the patient complained of sudden onset
of neck pain which was followed by massive haemoptysis. He
succumbed on the same day, just within three weeks since his
presentation of melioidosis relapse.
Discussion
Melioidosis is a granulomatous infectious disease caused by the
aerobic Gram-negative bacillus B. pseudomallei. It is an environ-
mental organism found in soils (classically rice paddy ﬁelds) and
contaminated waters. It is endemic in Southeast Asia and Northern
Australia with an expanding geographical distribution [1]. Like
many soil bacteria, it is a difﬁcult organism to kill, with an incu-
bation period ranging from 2 days to 26 years [2] and can survive
even in distilled water for up to 16 years [3]. Our patient was born
in Hong Kong and had never resided in a village with rice paddyFig. 1. PET-CT showing hypermetabolic mass at the left side of the superior mediastiﬁelds. It is likely that our patient was infected locally, given the
increasing reports of melioidosis in our locality [1,4] as well his
previous occupation as a water pipe worker. Although often pre-
senting as community-acquired pneumonia and sepsis, melioidosis
can involve almost any part of the body. In this case report, we
illustrate a rare but fatal complication of this increasingly reported
and important disease.
The disease can manifest as either acute or chronic forms and
has a wide range of presentations. Acute disease is deﬁned as
symptoms lasting for less than two months and chronic disease is
deﬁned as symptoms persisting for longer than two months [5].
Acutemelioidosis is more common and, such as in this case, around
half of patients present with chest complaints and are often
indistinguishable from other forms of community-acquired pneu-
monia. Other common presentations include skin infections,
genitourinary infections, osteomyelitis/septic arthritis and internal
organ abscesses (especially prostatic, splenic, kidney and liver ab-
scesses) [6]. Acute suppurative parotitis is a characteristic mani-
festation of melioidosis amongst children in Thailand, and has been
reported to account for around a third of all paediatric cases [7].
Melioidosis is also a rare but well documented cause of mycotic
aneurysms [8e10] and is described to occur in around 1% of
affected patients. In fact, B. pseudomallei was reported as the most
common causative agent of mycotic aneurysm in North-eastern
Thailand [10]. As with other causes of mycotic aneurysms, the
proposed mechanism is haematogenous seeding of previously
damaged arteriosclerotic vessels. Prolonged antibiotic therapy with
surgical intervention is considered the most appropriate manage-
ment for melioidosis-associated mycotic aneurysms.
B. pseudomallei is intrinsically resistant to many antibiotics and
current recommendations for antibiotic treatment includes initial
an intravenous intensive phase of at least 10e14 days and followed
by an oral eradication phase [11]. Usual ﬁrst-line therapy for the
intensive phase of treatment includes ceftazidime or a carbapenem.num, consistent with mycotic aneurysm of the aortic arch/left subclavian artery.
Fig. 2. Serial CXRs, taken 10 days apart (top) and contrast CT (bottom) showing rapid interval enlargement of the mycotic aneurysm.
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SMX) has not shown to have long-term outcome beneﬁt [12] and
ceftazidime alone is adequate for the intravenous phase in the
majority of cases. For the oral eradication phase, the recommended
minimum duration of treatment is 12 weeks. Although TMP-SMX
(with or without doxycycline) is the recommended ﬁrst-line
drug, it is associated with signiﬁcant adverse effects and intolera-
bility which can lead to poor drug compliance. As an alternative,
consensus guidelines for use of amoxicillin/clavulanic acid have
also been developed [13].
Despite completing a full course of therapy, the patient experi-
enced a recurrence of melioidosis and subsequently failed to
respond to multiple lines of treatment. Relapse of melioidosis is
considered rare with appropriate antibiotic therapy [14,15] and
there was also no evidence to suggest reinfection. Risk factors for
melioidosis include diabetes, hazardous alcohol use, chronic lung
disease and chronic renal disease [6]. Although the patient had
none of these risk factors, a low oxidative burst response was
observed on the DHR test. The DHR test is commonly used to test
for chronic granulomatous disease (CGD), a primary immunodeﬁ-
ciency characterized by defective generation of a respiratory burst
in phagocytes which leads to recurrent bacterial/fungal infections
associatedwith granuloma formation. Interestingly, CGD is strongly
associated with melioidosis and it has also been reported that
melioidosis could be the presenting infection in CGD patients
without the classical clinical phenotype (even in adults) [16].
B. pseudomallei can multiply within phagocytes and functional
neutrophil defects may be important in disease pathogenesis [17].Although further testing would be required to conﬁrm the presence
of any immunodeﬁciency, an impaired phagocytic function may
have contributed to the patient's persistent and fulminant course of
infection despite aggressive antibiotic therapy.
This cases illustrates a rare but fatal complication of an
emerging disease. Melioidosis can involve almost any organ and
can deteriorate rapidly. Themorbidity andmortality of melioidosis-
associated mycotic aneurysms are high despite prompt diagnosis
and treatment. Especially when treating persistent/recurrent
melioidosis, the physician's caution to the development of mycotic
aneurysms is imperative so that early treatment and surgical
intervention may be considered.Acknowledgements
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